Amarin Corp Plc (AMRN)

[Retire2019]

dumb question... according to JT, all AMRN knows is the adcomm delay, but they have not technically been notified of a delay in the sept 28th date. They are just assuming. Because the adcom is being done by endocrinology not cardiovascular, is there a chance, albeit small that they can still get a cardio label on sept 28th and the adcomm for endocrinology would be an add on later to cover diabetics or is that just not the way it works?
that may just be a pie in the sky way of looking at it, but even though that is probably not the case, it is encouraging that the adcom is being run through endocrinology vs cardio, no? it means less concern, and this is more for a broader label? when will we know?